VJHemOnc Podcast

VJHemOnc Podcast


Latest Episodes

Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents
December 18, 2024

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by involvement of the skin, bone...

Improving care for patients with SCD: pain management, ongoing projects & unmet needs
December 05, 2024

This weeks podcast focuses on strategies to improve care for patients with sickle cell disease (SCD), featuring expert insights from...

Understanding BPDCN: dermatology and hematology perspectives on presentation, diagnosis, treatment, & multidisciplinary care
November 28, 2024

In this podcast, experts Marlise Luskin, MD, MSCE, Dana-Farber Cancer Institute, Boston, MA, Nicole LeBoeuf, MD, MPH, Dana-Farber Cancer Institute,...

Managing complications associated with WM: Bing-Neel syndrome, acquired von Willebrand disease, & more!
November 19, 2024

Todays podcast episode focuses on the management of complications associated with Waldenstrms macroglobulinemia (WM), featuring expert insights from the 12th...

CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024
November 12, 2024

This weeks podcast features discussions on the use of immunotherapy in the treatment of high-risk multiple myeloma (HRMM) from the...

The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
November 06, 2024

This podcast features a discussion from the 6th International Workshop on Acute Leukemias (iwAL) 2024, which took place in Phoenix,...

Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events
October 30, 2024

Todays podcast focuses on the role of BTK inhibitors (BTKis) in the treatment of mantle cell lymphoma (MCL). You will...

An update on menin inhibition in AML from iwAL 2024: current data, mechanisms of resistance, & more!
October 23, 2024

Menin inhibitors are emerging as a promising therapeutic approach in acute myeloid leukemia (AML), particularly in patients with specific genetic...

CAR T-cells and bispecific antibodies in the treatment of NHL: updates from iwNHL 2024
October 15, 2024

Todays podcast features discussions from the 21st International Workshop on Non-Hodgkin Lymphoma (iwNHL) which took place in Nice, France. You...

Prolonging remission in AML: current approaches & future outlooks
October 08, 2024

Todays podcast features a discussion with leading experts Harry Erba, MD, PhD, Duke University, Durham, NC, Farhad Ravandi, MD, The...